Regulation of intestinal inflammation and tumorigenesis by Nlrp6
Nlrp6 对肠道炎症和肿瘤发生的调节
基本信息
- 批准号:8436792
- 负责人:
- 金额:$ 32.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-18 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAffectAnti-Inflammatory AgentsAspirinBacteriaBone MarrowCaspase-1Cell ProliferationCellsChemopreventive AgentChronicColitisColonColon CarcinomaColorectal CancerDataDevelopmentDiseaseEpithelialFamilyGenetic Predisposition to DiseaseGerm-FreeGoalsHematopoieticHumanImmuneImmune systemImmunologic ReceptorsIncidenceIndividualInflammationInflammatory Bowel DiseasesInflammatory disease of the intestineInjuryInterleukin-10Interleukin-18Intestinal CancerIntestinal NeoplasmsIntestinesLeadMacromolecular ComplexesMalignant NeoplasmsMediatingMediator of activation proteinMusObesityPatternPattern recognition receptorPlayPolypsPopulationPredispositionPremalignantProductionPropertyRegulationRoleSignal PathwaySignal TransductionSourceTestingToll-like receptorsTumor SuppressionTumor Suppressor ProteinsTumorigenicityUnited StatesWomancancer chemopreventioncancer riskcarcinogenesiscell typecolon carcinogenesiscommensal microbesdisorder riskgut microbiotahigh riskintestinal homeostasismembermenmicrobiomemouse modelnovelnovel strategiespathogenic bacteriapublic health relevancereceptorrepairedtumortumorigenesistumorigenic
项目摘要
DESCRIPTION (provided by applicant): Colorectal cancer is the third most common cancer in both men and women in the United States. The highest risk groups for developing colon cancer are those with a genetic predisposition and those with inflammatory bowel disease. For individuals with inflammatory bowel disease, the risk correlates with extent and duration of inflammation affecting the colon and can be increased 5- to 15-fold compared to normal individuals. Mouse models of inflammation-related colon cancer have demonstrated that intestinal bacteria and the host immune system can regulate intestinal inflammation and carcinogenesis. In particular, members of the Nod-like receptor family have emerged as important players in the development of intestinal inflammation and cancer. NLRs are intracellular pattern-recognition receptors that are involved in the sensing of both pathogenic and commensal bacteria within the gut. We have recently identified a relatively unknown member of the NLR family, Nlrp6, which is important for intestinal homeostasis and tumor suppression during chronic injury and inflammation within the colon. However, the mechanism by which Nlrp6 reduces tumor development and inflammation in the colon remains to be elucidated. We hypothesize that Nlrp6 modulates susceptibility to intestinal inflammation and tumorigenesis by regulating the composition of the gut microbiota and the production of IL-18. Our specific aims are: (1) to determine the importance of Nlrp6 in regulating the gut microbiome to increase susceptibility to colonic inflammation and cancer, (2) to identify the cell type that Nlrp6 functions in to suppress tumorigenesis, and 3) to understand the role of IL-18 in Nlrp6-mediated tumor suppression. The long-term goal of these studies is to increase our understanding of how interactions between NLRs and the gut microbiota regulate colon carcinogenesis, which may lead to novel chemopreventive strategies for colon cancer involving the manipulation of the intestinal bacteria and/or modulation of NLR signaling pathways.
描述(由申请人提供):大肠癌是美国男性和女性中第三大常见的癌症。发生结肠癌的最高风险组是患有遗传易感性的患者和患有炎症性肠病的患者。对于患有炎症性肠病的个体,风险与影响结肠的炎症程度和持续时间相关,与正常人相比可以增加5至15倍。与炎症相关结肠癌的小鼠模型表明,肠道细菌和宿主免疫系统可以调节肠道炎症和致癌。特别是,在肠道炎症和癌症的发展中,点头样受体家族的成员已成为重要的参与者。 NLR是细胞内模式识别受体,与肠内致病性和共生细菌的感知有关。我们最近确定了NLR家族NLRP6的一个相对未知的成员,这对于慢性损伤和结肠内炎症期间肠内稳态和肿瘤抑制很重要。但是,NLRP6降低结肠中肿瘤发育和炎症的机制仍有待阐明。我们假设NLRP6通过调节肠道菌群的组成和IL-18的产生来调节对肠炎和肿瘤发生的敏感性。我们的具体目的是:(1)确定NLRP6在调节肠道微生物组以增加对结肠炎症和癌症的敏感性方面的重要性,(2)确定NLRP6在抑制肿瘤中起作用的细胞类型,以抑制肿瘤的发生,而3)以了解IL-18在NLRP6介导的tumor介导的tumor tumor的作用。这些研究的长期目标是提高我们对NLR与肠道微生物群之间的相互作用如何调节结肠癌的理解,这可能会导致针对结肠癌的新型化学预防策略,涉及操纵NLR信号传导途径的肠道细菌和/或调模。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GRACE Y. CHEN其他文献
GRACE Y. CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GRACE Y. CHEN', 18)}}的其他基金
Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention
针对癌症干细胞样细胞和炎症进行结肠癌化学预防
- 批准号:
10650910 - 财政年份:2023
- 资助金额:
$ 32.27万 - 项目类别:
Understanding NLRP6 function in intestinal homeostasis
了解 NLRP6 在肠道稳态中的功能
- 批准号:
10393573 - 财政年份:2019
- 资助金额:
$ 32.27万 - 项目类别:
Dietary fiber and soy protein-based microbiome metabolites for IBD prevention
基于膳食纤维和大豆蛋白的微生物组代谢物用于预防 IBD
- 批准号:
10607658 - 财政年份:2018
- 资助金额:
$ 32.27万 - 项目类别:
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients
(10.) 直肠癌患者的肠道微生物群和对新辅助放化疗的反应
- 批准号:
9250105 - 财政年份:2016
- 资助金额:
$ 32.27万 - 项目类别:
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients
(10.) 直肠癌患者的肠道微生物群和对新辅助放化疗的反应
- 批准号:
9100263 - 财政年份:2016
- 资助金额:
$ 32.27万 - 项目类别:
Identifying bacterial regulators of tumorigenesis
识别肿瘤发生的细菌调节因子
- 批准号:
8982222 - 财政年份:2014
- 资助金额:
$ 32.27万 - 项目类别:
Identifying bacterial regulators of tumorigenesis
识别肿瘤发生的细菌调节因子
- 批准号:
8814012 - 财政年份:2014
- 资助金额:
$ 32.27万 - 项目类别:
Regulation of intestinal inflammation and tumorigenesis by Nlrp6
Nlrp6 对肠道炎症和肿瘤发生的调节
- 批准号:
8606443 - 财政年份:2013
- 资助金额:
$ 32.27万 - 项目类别:
Role of the immune receptor Nod1 in inflammation-associated colon tumorigenesis
免疫受体Nod1在炎症相关结肠肿瘤发生中的作用
- 批准号:
7588189 - 财政年份:2008
- 资助金额:
$ 32.27万 - 项目类别:
Role of the immune receptor Nod1 in inflammation-associated colon tumorigenesis
免疫受体Nod1在炎症相关结肠肿瘤发生中的作用
- 批准号:
7912863 - 财政年份:2008
- 资助金额:
$ 32.27万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Effects of binge ethanol on neuroinflammation and neurodegeneration with high fat diets
暴饮乙醇对高脂肪饮食引起的神经炎症和神经变性的影响
- 批准号:
10668068 - 财政年份:2023
- 资助金额:
$ 32.27万 - 项目类别:
Differential regulation of T cell plasma membrane proteins by N-glycan branching and clathrin-mediated endocytosis
N-聚糖分支和网格蛋白介导的内吞作用对 T 细胞质膜蛋白的差异调节
- 批准号:
10295564 - 财政年份:2022
- 资助金额:
$ 32.27万 - 项目类别:
Comparing the role of MyD88 and TRIF in T-cell effector function and the development of heart failure
比较 MyD88 和 TRIF 在 T 细胞效应功能和心力衰竭发展中的作用
- 批准号:
10534476 - 财政年份:2022
- 资助金额:
$ 32.27万 - 项目类别:
Regulation of Proinflammatory Cytokine Responses by a Caspase-8-N4BP1 Axis
Caspase-8-N4BP1 轴对促炎细胞因子反应的调节
- 批准号:
10704065 - 财政年份:2022
- 资助金额:
$ 32.27万 - 项目类别:
Comparing the role of MyD88 and TRIF in T-cell effector function and the development of heart failure
比较 MyD88 和 TRIF 在 T 细胞效应功能和心力衰竭发展中的作用
- 批准号:
10733439 - 财政年份:2022
- 资助金额:
$ 32.27万 - 项目类别: